Home

Evommune, Inc. Common Stock (EVMN)

19.69
+0.08 (0.41%)
NYSE · Last Trade: Dec 12th, 3:01 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close19.61
Open19.96
Bid18.71
Ask21.50
Day's Range19.45 - 20.54
52 Week Range16.70 - 24.03
Volume265,185
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume96,782

Chart

News & Press Releases

Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update
Evommune, Inc. (NYSE: EVMN) (the “Company”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update.
By Evommune, Inc. · Via Business Wire · December 11, 2025